Cardiovascular diseases (CVDs) are a serious public health issue that affects and is responsible for numerous fatalities and impairments. Ischemic heart disease (IHD) is one of the most prevalent and deadliest types of CVDs and is responsible for 45% of all CVD-related fatalities. IHD occurs when the blood supply to the heart is reduced due to narrowed or blocked arteries, which causes angina pectoris (AP) chest pain. AP is a common symptom of IHD and can indicate a higher risk of heart attack or sudden cardiac death. Therefore, it is important to diagnose and treat AP promptly and effectively. To forecast AP in women, we constructed a novel artificial intelligence (AI) method employing the tree-based algorithm known as an Explainable Boosting Machine (EBM). EBM is a machine learning (ML) technique that combines the interpretability of linear models with the flexibility and accuracy of gradient boosting. We applied EBM to a dataset of 200 female patients, 100 with AP and 100 without AP, and extracted the most relevant features for AP prediction. We then evaluated the performance of EBM against other AI methods, such as Logistic Regression (LR), Categorical Boosting (CatBoost), eXtreme Gradient Boosting (XGBoost), Adaptive Boosting (AdaBoost), and Light Gradient Boosting Machine (LightGBM). We found that EBM was the most accurate and well-balanced technique for forecasting AP, with accuracy (0.925) and Youden's index (0.960). We also looked at the global and local explanations provided by EBM to better understand how each feature affected the prediction and how each patient was classified. Our research showed that EBM is a useful AI method for predicting AP in women and identifying the risk factors related to it. This can help clinicians to provide personalized and evidence-based care for female patients with AP.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10719282PMC
http://dx.doi.org/10.1038/s41598-023-49673-2DOI Listing

Publication Analysis

Top Keywords

gradient boosting
12
artificial intelligence
8
angina pectoris
8
boosting machine
8
female patients
8
ebm
7
boosting
6
proposed tree-based
4
tree-based explainable
4
explainable artificial
4

Similar Publications

Background: Postoperative delirium (POD) is a common complication after major surgery and is associated with poor outcomes in older adults. Early identification of patients at high risk of POD can enable targeted prevention efforts. However, existing POD prediction models require inpatient data collected during the hospital stay, which delays predictions and limits scalability.

View Article and Find Full Text PDF

pmiRScan: a LightGBM based method for prediction of animal pre-miRNAs.

Funct Integr Genomics

January 2025

Computational Structural Biology Lab, Department of Bioscience and Biotechnology, Indian Institute of Technology Kharagpur, Kharagpur, West Bengal, 721302, India.

MicroRNAs (miRNA) are categorized as short endogenous non-coding RNAs, which have a significant role in post-transcriptional gene regulation. Identifying new animal precursor miRNA (pre-miRNA) and miRNA is crucial to understand the role of miRNAs in various biological processes including the development of diseases. The present study focuses on the development of a Light Gradient Boost (LGB) based method for the classification of animal pre-miRNAs using various sequence and secondary structural features.

View Article and Find Full Text PDF

Proteolysis-targeting chimeras (PROTACs) are heterobifunctional molecules that target undruggable proteins, enhance selectivity and prevent target accumulation through catalytic activity. The unique structure of PROTACs presents challenges in structural identification and drug design. Liquid chromatography (LC), combined with mass spectrometry (MS), enhances compound annotation by providing essential retention time (RT) data, especially when MS alone is insufficient.

View Article and Find Full Text PDF

Biomarkers.

Alzheimers Dement

December 2024

Brown University, Providence, RI, USA.

Background: Predicting amyloid and tau status in nondemented older adults with AD pathologies using more affordable and accessible measures can facilitate clinical trials by reducing the screen failure rate. The goal of the present study was to develop tree-based ensemble models to predict PET-based amyloid and tau burden using non-invasive measures.

Method: Two datasets, amyloid (Aβ; n = 1062) and tau (n = 410), from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database were used to predict the biomarker load in the subjects with normal cognition and mild cognitive impairment.

View Article and Find Full Text PDF

Biomarkers.

Alzheimers Dement

December 2024

Eisai Inc., Nutley, NJ, USA.

Background: Reductions in medial temporal lobe (MTL) volume, particularly in the amygdala and hippocampus, are present in early Alzheimer's disease (AD). We explore the correlations between hippocampal and amygdalar subfield volumes and brain amyloid-β (Aβ) accumulation using T1-weighted structural MRI and amyloid PET data from ADNI and Eisai clinical trials.

Method: We used FreeSurfer (v7.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!